Xtend AI Robotics grants counsel 570,000 stock units

The award combines a monthly service-based tranche with two tranches tied to performance targets and 2027 deadlines.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Xtend AI Robotics, Inc. reported that Chief Legal Counsel Mor Swiel received awards on October 23, 2026, under its 2026 Equity Incentive Plan in connection with an employment-agreement amendment: 190,000 restricted stock units (RSUs) and 380,000 performance restricted stock units (PRSUs), the second and third tranches of a 570,000-RSU grant. The 190,000-RSU tranche vests in 36 equal monthly installments beginning September 3, 2026, subject to continued service. The PRSU tranches vest over 36 months, subject to key performance indicator achievement by March 1, 2027, and September 1, 2027, respectively, and continued service. Swiel's reported common-stock position after the 190,000-unit award was 824,484 shares.

Insider Trade Summary

Grant/Award: 570,000 shares

Grant/Award 2 txns

Insider Swiel Mor

Role Chief Legal Counsel

Type	Security	Shares	Price	Value
Grant/Award	Performance Restricted Stock Units ^{F3, F4, F5}	380,000	$0.00	$0.00
Grant/Award	Common Stock ^{F1, F2}	190,000	$0.00	$0.00

Holdings After Transaction: Performance Restricted Stock Units — 380,000 contracts (Direct); Common Stock — 824,484 shares (Direct)

Footnotes (5)

F1. Represents restricted stock units ("RSUs") granted under the Issuer's 2026 Equity Incentive Plan to the Reporting Person in connection with an amendment to his employment agreement with the Issuer. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2. Represents the first of three equal tranches of 190,000 RSUs comprising a total grant of 570,000 RSUs. This first tranche is not subject to any key performance indicators and vests over a period of 36 months in 36 equal monthly installments commencing on September 3, 2026, in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
F3. Represents performance restricted stock units ("PRSUs") comprising the second and third tranches of 190,000 PRSUs each, of the total grant of 570,000 RSUs described in footnote (2), the vesting of which is conditioned upon the achievement of key performance indicators. Each PRSU represents a contingent right to receive one share of common stock of the Issuer.
F4. Each PRSU converts into one share of common stock of the Issuer upon vesting.
F5. Each of the second and third tranches vests over a period of 36 months in 36 equal monthly installments, with vesting beginning on September 3, 2026, provided that (i) the vesting of the second tranche is conditioned upon the achievement of the applicable key performance indicators on or prior to March 1, 2027, and (ii) the vesting of the third tranche is conditioned upon the achievement of the applicable key performance indicators on or prior to September 1, 2027, in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Key Figures

Total grant: 570,000 RSUs First tranche: 190,000 RSUs Performance restricted stock units: 380,000 PRSUs +5 more

8 metrics

Total grant 570,000 RSUs Grant comprising three equal tranches

First tranche 190,000 RSUs First of three equal tranches; not subject to key performance indicators

Performance restricted stock units 380,000 PRSUs Second and third tranches, 190,000 PRSUs each

Common-stock position after transaction 824,484 shares Reported following the October 23, 2026 award

Vesting period 36 months Each tranche vests in 36 equal monthly installments

Second-tranche KPI deadline March 1, 2027 Applicable key performance indicators must be achieved on or before this date

Third-tranche KPI deadline September 1, 2027 Applicable key performance indicators must be achieved on or before this date

Common shares per PRSU 1 share Contingent right upon vesting

Key Terms

restricted stock units ("RSUs"), performance restricted stock units ("PRSUs"), key performance indicators, contingent right

4 terms

restricted stock units ("RSUs") financial

"restricted stock units ("RSUs") granted under the Issuer's 2026 Equity Incentive Plan"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

performance restricted stock units ("PRSUs") financial

"performance restricted stock units ("PRSUs") comprising the second and third tranches"

key performance indicators financial

"vesting of the second tranche is conditioned upon the achievement of the applicable key performance indicators"

Key performance indicators are specific measurements used to track how well a person, team, or organization is achieving its goals. They act like report cards, providing clear signs of progress or areas needing improvement. For investors, KPIs help assess the health and future potential of a business by highlighting its most important strengths and challenges.

contingent right financial

"Each PRSU represents a contingent right to receive one share of common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did XTND's chief legal counsel receive?

On October 23, 2026, Chief Legal Counsel Mor Swiel received 190,000 RSUs and 380,000 PRSUs, comprising the second and third tranches of a 570,000-RSU grant. Each PRSU represents a contingent right to receive one share of common stock.

What are the vesting conditions for Mor Swiel's XTND PRSUs?

The second and third PRSU tranches vest over 36 months, subject to continued service and achievement of their applicable key performance indicators. The deadlines are March 1, 2027, for the second tranche and September 1, 2027, for the third.

How many XTND common shares did Mor Swiel report after the award?

Swiel's reported common-stock position following the 190,000-unit award was 824,484 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/27/2026 - 04:11 PM EDT Accepted by SEC EDGAR 10/27/2026 - 04:10 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Swiel Mor

(Last)

(First)

(Middle)

C/O XTEND AI ROBOTICS, INC.

5247 CROSSROADS PARK DRIVE

(Street)

TAMPA

FLORIDA

33610

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Xtend AI Robotics, Inc. [ XTND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	10/23/2026		A		190,000⁽²⁾	A	$0	824,484	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Restricted Stock Units⁽³⁾	⁽⁴⁾	10/23/2026		A		380,000		⁽⁵⁾	⁽⁵⁾	Common Stock	380,000	$0	380,000	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted under the Issuer's 2026 Equity Incentive Plan to the Reporting Person in connection with an amendment to his employment agreement with the Issuer. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

2. Represents the first of three equal tranches of 190,000 RSUs comprising a total grant of 570,000 RSUs. This first tranche is not subject to any key performance indicators and vests over a period of 36 months in 36 equal monthly installments commencing on September 3, 2026, in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

3. Represents performance restricted stock units ("PRSUs") comprising the second and third tranches of 190,000 PRSUs each, of the total grant of 570,000 RSUs described in footnote (2), the vesting of which is conditioned upon the achievement of key performance indicators. Each PRSU represents a contingent right to receive one share of common stock of the Issuer.

4. Each PRSU converts into one share of common stock of the Issuer upon vesting.

5. Each of the second and third tranches vests over a period of 36 months in 36 equal monthly installments, with vesting beginning on September 3, 2026, provided that (i) the vesting of the second tranche is conditioned upon the achievement of the applicable key performance indicators on or prior to March 1, 2027, and (ii) the vesting of the third tranche is conditioned upon the achievement of the applicable key performance indicators on or prior to September 1, 2027, in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

	/s/ Aviv Shapira, as Attorney-in-Fact for Mor Swiel	10/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR